home / stock / vph:cc / vph:cc quote
Last: | $0.65 |
---|---|
Change Percent: | -1.52% |
Open: | $0.66 |
Close: | $0.65 |
High: | $0.67 |
Low: | $0.65 |
Volume: | 74,087 |
Last Trade Date Time: | 03/21/2022 04:54:28 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.65 | $0.66 | $0.65 | $0.67 | $0.65 | 74,087 | 03-21-2022 |
$0.62 | $0.64 | $0.62 | $0.64 | $0.61 | 89,698 | 03-17-2022 |
$0.6 | $0.59 | $0.6 | $0.61 | $0.57 | 286,377 | 03-16-2022 |
$0.58 | $0.59 | $0.58 | $0.59 | $0.57 | 45,025 | 03-15-2022 |
$0.6 | $0.58 | $0.6 | $0.6 | $0.58 | 233,860 | 03-14-2022 |
$0.56 | $0.58 | $0.56 | $0.58 | $0.56 | 49,039 | 03-11-2022 |
$0.57 | $0.57 | $0.57 | $0.57 | $0.49 | 415,580 | 03-10-2022 |
$0.52 | $0.61 | $0.52 | $0.62 | $0.52 | 457,080 | 03-09-2022 |
$0.61 | $0.62 | $0.61 | $0.62 | $0.58 | 77,501 | 03-08-2022 |
$0.62 | $0.63 | $0.62 | $0.63 | $0.61 | 51,900 | 03-07-2022 |
$0.63 | $0.64 | $0.63 | $0.64 | $0.62 | 38,825 | 03-04-2022 |
$0.64 | $0.65 | $0.64 | $0.65 | $0.62 | 170,300 | 03-03-2022 |
$0.64 | $0.67 | $0.64 | $0.67 | $0.63 | 116,395 | 03-02-2022 |
$0.68 | $0.66 | $0.68 | $0.68 | $0.66 | 91,100 | 03-01-2022 |
$0.63 | $0.63 | $0.63 | $0.64 | $0.62 | 103,351 | 02-25-2022 |
$0.63 | $0.63 | $0.63 | $0.64 | $0.6 | 64,416 | 02-24-2022 |
$0.63 | $0.64 | $0.63 | $0.64 | $0.63 | 31,310 | 02-23-2022 |
$0.63 | $0.63 | $0.63 | $0.64 | $0.63 | 57,658 | 02-22-2022 |
$0.61 | $0.63 | $0.61 | $0.63 | $0.61 | 50,143 | 02-18-2022 |
$0.63 | $0.63 | $0.63 | $0.63 | $0.63 | 4,569 | 02-17-2022 |
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
--News Direct-- Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million ...
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES Canada NewsWire Record Q2-24 revenues of $14.1 million , up 4% over Q2-23 outpacing revenue softness in several non-core brands Q2-24 adjusted EBITDA loss of $2.5 million compared to $1.7 million fo...